Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06220370

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Kirby Institute · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We seek to characterise the burden and outcomes of and understand the current experience of people who inject drugs admitted to hospital with invasive injecting-related infections, in order to implement and evaluate strategies to improve completion of therapy and reduce patient-directed discharges, with ultimate benefit to the patient and health service.

Detailed description

This study will be conducted as a prospective, observational cohort study of adults admitted with invasive bacterial and fungal infectious diseases. This study will be conducted at multiple hospitals in Australia. Participants will be invited for Screening whilst they are inpatients of the hospital. Participants will be screened for history of injection drug use in the last 6 months and presence of an invasive bacterial or fungal infection. Eligible participants will be treated through standard of care with the applicable treatment. All participants will commence antimicrobial treatment whilst they are inpatients. For participants who are discharged before planned treatment completion, a hospital discharge visit (Early Discharge Electronic Case Report Form \[eCRF\]) will be conducted. Following the end of treatment, participants will be reviewed at 6, 12 and 48-weeks post-enrolment. At follow-up visits, behavioural surveys, health-related quality of life, and experiences with hospital care will be assessed. Individual patient involvement will include four visits over a 12-month period. The duration of the study is anticipated to be 5 years.

Conditions

Interventions

TypeNameDescription
OTHERObservationalThere is no clinical intervention as part of this study. Participants will receive treatment as per their clinical treating team.

Timeline

Start date
2024-03-01
Primary completion
2029-03-01
Completion
2029-03-01
First posted
2024-01-23
Last updated
2024-02-20

Source: ClinicalTrials.gov record NCT06220370. Inclusion in this directory is not an endorsement.